Top Tweets for #AboundBio

over 4 years ago

How do you make a VH-only binder library more diverse than camelid-based approaches, with fully human sequences? Pleased to be part of the latest insights from Zehua Sun & Mitko @seattlechildren @UPMC #AboundBio #CD22 https://t.co/vI582OZCyg

The Chain @TheChainPodcast

over 5 years ago

NEW EPISODE! A timely discussion with Dimiter Dimitrov, Director of #CenterforAntibodyTherapeutics @PittDeptofMed and #AboundBio on the vast potential of human VH domains (hint: including for #COVID19): https://t.co/N5BFcCzvCI @CHI_Healthtech

TheChainPodcast's tweet photo. NEW EPISODE! A timely discussion with Dimiter Dimitrov, Director of #CenterforAntibodyTherapeutics
@PittDeptofMed and #AboundBio on the vast potential of human VH domains (hint: including for #COVID19): https://t.co/N5BFcCzvCI
@CHI_Healthtech https://t.co/iaXsaosVjS

Riikka Kevo 🇪🇺🇺🇦✙ @riikka_kevo

about 6 years ago

.. and also makes it possible to use the #drug by alternative routes, like #Inhalation. Importantly, it #DoesNotBind to human cells. Novel #COVID19 therapeutics are urgently needed. @PittTweet! #AboundBio has licensed Ab8 for worldwide development. ✨ https://t.co/puDOMtXmbD

Mazen Hassanain @HassanainMazen

over 6 years ago

Potent neutralization of SARS-CoV-2 in vitro and in an animal model by a human monoclonal antibody | bioRxiv ⁦@UPMC⁩ ⁦@UPittPress⁩ #AboundBio https://t.co/A3IDvLgXwM

Top Tweets for #AboundBio

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users